Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Piperi

Showing results (111-120 of 252) with videos related to

Pageof 26
Sort By:
Molecular Neurobiology|November 11, 2020
Pivotal Role of Fyn Kinase in Parkinson's Disease and Levodopa-Induced Dyskinesia: a Novel Therapeutic Target?Efthalia Angelopoulou, Yam Nath Paudel, Thomas Julian, et al.
The Journal of Clinical Endocrinology and Metabolism|April 18, 2012
Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseasesChristina Piperi, Christos Adamopoulos, Georgia Dalagiorgou, et al.
International Journal of Molecular Sciences|July 3, 2020
HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic OpportunitiesYam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, et al.
Neuropathology and Applied Neurobiology|August 19, 2021
Emerging roles for the YAP/TAZ transcriptional regulators in brain tumour pathology and targeting optionsDimitrios Strepkos, Mariam Markouli, Kostas A Papavassiliou, et al.
Annals of the New York Academy of Sciences|December 8, 2006
Inflammatory process in type 2 diabetes: The role of cytokinesKrystallenia Alexandraki, Christina Piperi, Christos Kalofoutis, et al.
Biology|April 29, 2020
Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson's Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading PathologyEfthalia Angelopoulou, Yam Nath Paudel, Chiara Villa, et al.
Pharmacological Research|April 12, 2020
Implication of HMGB1 signaling pathways in Amyotrophic lateral sclerosis (ALS): From molecular mechanisms to pre-clinical resultsYam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, et al.
Biology|June 18, 2020
Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and TauYam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, et al.
Life Sciences|October 14, 2019
High mobility group box 1 (HMGB1) protein in Multiple Sclerosis (MS): Mechanisms and therapeutic potentialYam Nath Paudel, Efthalia Angelopoulou, Bhuvan K C, et al.
Experimental and Clinical Cardiology|July 25, 2008
Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approachesChristos Kalofoutis, Christina Piperi, Anastasios Kalofoutis, et al.
Pageof 26

Showing results (111-120 of 252) with videos related to

Sort By:
Pageof 26
Molecular Neurobiology|November 11, 2020
Pivotal Role of Fyn Kinase in Parkinson's Disease and Levodopa-Induced Dyskinesia: a Novel Therapeutic Target?Efthalia Angelopoulou, Yam Nath Paudel, Thomas Julian, et al.
The Journal of Clinical Endocrinology and Metabolism|April 18, 2012
Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseasesChristina Piperi, Christos Adamopoulos, Georgia Dalagiorgou, et al.
International Journal of Molecular Sciences|July 3, 2020
HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic OpportunitiesYam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, et al.
Neuropathology and Applied Neurobiology|August 19, 2021
Emerging roles for the YAP/TAZ transcriptional regulators in brain tumour pathology and targeting optionsDimitrios Strepkos, Mariam Markouli, Kostas A Papavassiliou, et al.
Annals of the New York Academy of Sciences|December 8, 2006
Inflammatory process in type 2 diabetes: The role of cytokinesKrystallenia Alexandraki, Christina Piperi, Christos Kalofoutis, et al.
Biology|April 29, 2020
Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson's Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading PathologyEfthalia Angelopoulou, Yam Nath Paudel, Chiara Villa, et al.
Pharmacological Research|April 12, 2020
Implication of HMGB1 signaling pathways in Amyotrophic lateral sclerosis (ALS): From molecular mechanisms to pre-clinical resultsYam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, et al.
Biology|June 18, 2020
Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and TauYam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, et al.
Life Sciences|October 14, 2019
High mobility group box 1 (HMGB1) protein in Multiple Sclerosis (MS): Mechanisms and therapeutic potentialYam Nath Paudel, Efthalia Angelopoulou, Bhuvan K C, et al.
Experimental and Clinical Cardiology|July 25, 2008
Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approachesChristos Kalofoutis, Christina Piperi, Anastasios Kalofoutis, et al.
Pageof 26